Pharmacia-Leiras launches hormone-release intra-uterine device (IUD)
This article was originally published in Clinica
Pharmacia-Leiras has launched Mirena, a hormone-releasing intra-uterine device, in the UK. The contraceptive action of the T-shaped device relies on local delivery of levonorgestrel from a cylindrical reservoir around the stem of the implant. The hormone is released at a rate of 20 ug/day and plasma concentrations are lower than those experienced with oral contraceptives. The device is designed to last for five years. Product launches in Belgium and Switzerland are planned this year.
You may also be interested in...
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.